CYTORI THERAPEUTICS, INC. AMENDMENT TO SERIES A-2 WARRANT TO PURCHASE COMMON STOCKCytori Therapeutics, Inc. • March 11th, 2016 • Surgical & medical instruments & apparatus • New York
This Amendment (the “Amendment”) to Series A-2 Warrant to Purchase Common Stock issued August 27, 2015 (the “Warrant”), is made and entered into effective as of December 17, 2015 (the “Effective Date”), by and among Cytori Therapeutics, Inc., a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”).
AGREEMENT FOR ACCELERATION AND/OR SEVERANCEAgreement for Acceleration And • March 11th, 2016 • Cytori Therapeutics, Inc. • Surgical & medical instruments & apparatus • California
This agreement (this “Agreement”) is entered into and is effective as of __________, between CYTORI THERAPEUTICS, INC., a Delaware corporation (the “Company”) and ___________ (“Executive”), setting forth the following terms and conditions.
CYTORI THERAPEUTICS, INC. AMENDMENT TO COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • March 11th, 2016 • Cytori Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
This Amendment (the “Amendment”) to Common Stock Purchase Warrant issued October 13, 2014 (the “Warrant”), is made and entered into effective as of December 17, 2015 (the “Effective Date”), by and among Cytori Therapeutics, Inc., a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”).
AMENDMENT ONE TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 11th, 2016 • Cytori Therapeutics, Inc. • Surgical & medical instruments & apparatus
This Amendment One to Securities Purchase Agreement (this “Amendment”) is made as of December 17, 2015 (the “Effective Date”), by and between Cytori Therapeutics, Inc., a Delaware corporation (the “Company”), and the undersigned investors (the “Investors”).
